Media

GenSight Biologics announces positive Data Safety Monitoring Board review and continuation of PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa

GenSight Biologics announces presentation of 72-week data from the REVERSE Phase III trial of GS010 at the Annual Meeting of the American Academy of Neurology (AAN)

MIPS – WORLD’S FIRST HOCKEY HELMET WITH MIPS BRAIN PROTECTION SYSTEM ANNOUNCED

MIPS INTERIM REPORT JAN – MAR 2019

BONESUPPORT HOLDING AB (publ) – Published Q1 2019 Interim report

Interim Report Q1 2019

Rainier Therapeutics Announces Appointment of Gary Christianson as Chief Technical Officer

Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update

Pulmonx Announces That HUMANA Has Issued a Positive Coverage Policy for the Zephyr Valve, a Less Invasive Treatment Option for Severe Emphysema (COPD)

Nordic Nanovector appoints Fredrik Haavind as Head of Legal and Compliance